154 related articles for article (PubMed ID: 33641087)
1. Serum calprotectin as a novel biomarker for severity of COVID-19 disease.
Kaya T; Yaylacı S; Nalbant A; Yıldırım İ; Kocayiğit H; Çokluk E; Şekeroğlu MR; Köroğlu M; Güçlü E
Ir J Med Sci; 2022 Feb; 191(1):59-64. PubMed ID: 33641087
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).
García de Guadiana-Romualdo L; Rodríguez Rojas C; Morell-García D; Andaluz-Ojeda D; Rodríguez Mulero MD; Rodríguez-Borja E; Ballesteros-Vizoso A; Calvo MD; Albert-Botella L; Pozo Giráldez A; Llompart-Alabern I; Bolado Jiménez C; Hernández Olivo M; Fernández Presa L; Ortega-Pérez J; Fora Romero MJ; Campos-Rodríguez V; Ballester Férriz A; Guiu-Martí AM; Pinilla Arribas L; Galindo Martínez M; Puerto-Lara ER; López Tarazaga AB; Ros Braquehais MS; Nogales Martín L; Juez Santamaría C; Trapiello Fernández W; Espinilla Fernández V; Havelka A; Albaladejo-Otón MD
Inflamm Res; 2022 Jan; 71(1):57-67. PubMed ID: 34718856
[TBL] [Abstract][Full Text] [Related]
3. Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients.
Larsson A; Tydén J; Johansson J; Lipcsey M; Bergquist M; Kultima K; Mandic-Havelka A
Scand J Clin Lab Invest; 2020; 80(2):156-161. PubMed ID: 31841042
[TBL] [Abstract][Full Text] [Related]
4. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.
Lee A; Nahm CH; Lee JS; Lee MK; Lee KR
J Clin Lab Anal; 2021 Nov; 35(11):e24004. PubMed ID: 34608677
[TBL] [Abstract][Full Text] [Related]
5. Serial measurement of circulating calprotectin as a prognostic biomarker in COVID-19 patients in intensive care setting.
Nevejan L; Strypens T; Van Nieuwenhove M; Boel A; Cattoir L; Van Vaerenbergh K; Meeus P; Bossuyt X; De Neve N; Van Hoovels L
Clin Chem Lab Med; 2023 Feb; 61(3):494-502. PubMed ID: 36473060
[TBL] [Abstract][Full Text] [Related]
6. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study.
Infantino M; Manfredi M; Alessio MG; Previtali G; Grossi V; Benucci M; Faraone A; Fortini A; Grifoni E; Masotti L; Russo E; Amedei A; FitzGerald E; Albesa R; Norman GL; Mahler M
J Med Virol; 2022 Dec; 94(12):5758-5765. PubMed ID: 35941084
[TBL] [Abstract][Full Text] [Related]
8. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
[TBL] [Abstract][Full Text] [Related]
9. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
Cherubini F; Cristiano A; Valentini A; Bernardini S; Nuccetelli M
Inflamm Res; 2021 Jun; 70(6):687-694. PubMed ID: 33956194
[TBL] [Abstract][Full Text] [Related]
10. Performance of plasma calprotectin as a biomarker of early sepsis: a pilot study.
Simm M; Söderberg E; Larsson A; Castegren M; Nilsen T; Eriksson M; Lipcsey M
Biomark Med; 2016 Aug; 10(8):811-8. PubMed ID: 27414210
[TBL] [Abstract][Full Text] [Related]
11. Plasma calprotectin as an indicator of need of transfer to intensive care in patients with suspected sepsis at the emergency department.
Parke Å; Unge C; Yu D; Sundén-Cullberg J; Strålin K
BMC Emerg Med; 2023 Feb; 23(1):16. PubMed ID: 36774492
[TBL] [Abstract][Full Text] [Related]
12. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
[TBL] [Abstract][Full Text] [Related]
13. Circulating calprotectin levels four months after severe and non-severe COVID-19.
Abu Hussein N; Machahua C; Ruchti SC; Horn MP; Piquilloud L; Prella M; Geiser TK; von Garnier C; Funke-Chambour M
BMC Infect Dis; 2023 Oct; 23(1):650. PubMed ID: 37789266
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
Chapuis N; Ibrahimi N; Belmondo T; Goulvestre C; Berger AE; Mariaggi AA; Andrieu M; Chenevier-Gobeaux C; Bayle A; Campos L; Cheurfa C; Chocron R; Diehl JL; Doumenc B; Duchemin J; Duprat M; François F; Gendron N; Mirault T; Pène F; Philippe A; Pommeret F; Sanchez O; Smadja DM; Szwebel TA; Silvin A; Ginhoux F; Lacroix L; Jules-Clément G; Rapeteramana S; Mavier C; Steller L; Perniconi B; André F; Drubay D; Fontenay M; Hüe S; Paul S; Solary E
EBioMedicine; 2022 Jun; 80():104077. PubMed ID: 35644124
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
Med Clin (Barc); 2021 Apr; 156(7):324-331. PubMed ID: 33422296
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.
García-Arias M; Pascual-Salcedo D; Ramiro S; Ueberschlag ME; Jermann TM; Cara C; Martín-Mola E; Balsa A
Mol Diagn Ther; 2013 Feb; 17(1):49-56. PubMed ID: 23329363
[TBL] [Abstract][Full Text] [Related]
17. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
Inciarte-Mundo J; Ruiz-Esquide V; Hernández MV; Cañete JD; Cabrera-Villalba SR; Ramirez J; Yagüe J; Sanmarti R
Rheumatology (Oxford); 2015 Dec; 54(12):2239-43. PubMed ID: 26242859
[TBL] [Abstract][Full Text] [Related]
18. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study.
Gatselis NK; Lyberopoulou A; Lygoura V; Giannoulis G; Samakidou A; Vaiou A; Antoniou K; Triantafyllou K; Stefos A; Georgiadou S; Sagris D; Sveroni D; Gabeta S; Ntaios G; Norman GL; Dalekos GN
Eur J Intern Med; 2024 Apr; 122():78-85. PubMed ID: 37953124
[TBL] [Abstract][Full Text] [Related]
19. A novel prognostic biomarker for recurrent aphthous stomatitis: calprotectin.
Kayabasi S; Kuzucu I
J Laryngol Otol; 2019 Aug; 133(8):691-695. PubMed ID: 31284886
[TBL] [Abstract][Full Text] [Related]
20. Serum calprotectin can indicate current and future severity of COVID-19.
Shokri-Afra H; Moradi M; Musavi H; Moradi-Sardareh H; Moradi Poodeh B; Kazemi Veisari A; Oladi Z; Ebrahimi M
J Clin Lab Anal; 2023 Jan; 37(1):e24809. PubMed ID: 36525302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
